Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.
Press releases published on April 23, 2025
Tinubu Agrees to Acquire Innoveo, Strengthening Leadership in Cloud Software for Specialty Insurance
EIN Presswire
·
April 23, 2025
NEW YORK, PARIS, FRANCE, April 23, 2025 /EINPresswire.com/ -- Tinubu, a leading provider of enterprise software solutions for the global specialty insurance industry, announces that it has signed a definitive agreement for the acquisition of Innoveo, a …
DTW Ignite 2025 Returns to Copenhagen In June To Unlock Pathways To Growth For The Global Telco Industry
EIN Presswire
·
April 23, 2025
Discuss Real Challenges, Develop Real Solutions And Create Real Change LONDON, UNITED KINGDOM, April 23, 2025 /EINPresswire.com/ -- The global telco industry has a pivotal role to play in the AI-era, and this year it will come together once again at …
2025 Drama Show Together With Family Members' Semifinals Showcase Dramatic Brilliance
EIN Presswire
·
April 23, 2025
NEW YORK, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- The Drama Show Together With Family Members, jointly organized by the Office of Spiritual Civilization of Jing'an District, Bureau of Culture and Tourism of Jing'an District, and Little …
Enchampion matures the GaAs solar panel solution with best cost and performance for space applications
EIN Presswire
·
April 23, 2025
MUNICH, GERMANY, April 23, 2025 /EINPresswire.com/ -- With years of technical and cost optimization, Enchampion Aerospace Technology turns its low-cost triple junction GaAs solar panel solution into an ideal solution for satellite and other space …
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
GlobeNewswire
·
April 23, 2025
PRESS RELEASE EUROPEAN MEDICINES AGENCY (EMA) HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - FR0010557264 - AB) announces today …
La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
GlobeNewswire
·
April 23, 2025
COMMUNIQUE DE PRESSE LA MOLECULE AB8939 OBTIENT LA DESIGNATION DE MEDICAMENT ORPHELIN DANS L’UNION EUROPEENNE AUPRES DE L’AGENCE EUROPEENNE DES MEDICAMENTS (EMA) DANS LE TRAITEMENT DE LA LEUCEMIE MYELOÏDE AIGUE Paris, 23 avril 2025, 18h45 AB Science SA ( …
PRESS RELEASE: NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES
GlobeNewswire
·
April 23, 2025
NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES Lesquin (France), April 23 2025 – NACON, a world leader in gaming accessories, is pleased to announce that its new Revolution X Unlimited (RXU) controller is now available. Particularly suited for …
COMMUNIQUE DE PRESSE: LA REVOLUTION X UNLIMITED EST DISPONIBLE EN MAGASIN
GlobeNewswire
·
April 23, 2025
LA REVOLUTION X UNLIMITED EST DISPONIBLE EN MAGASIN Lesquin (France), le 23 Avril 2025 – NACON, société qui figure parmi les leaders mondiaux des accessoires Gaming, est heureux d’annoncer que sa nouvelle manette, la Revolution X Unlimited, (RXU), est …
OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025
GlobeNewswire
·
April 23, 2025
OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 Featuring proprietary asset Tedopi® and two partnered SIRPα inhibitor assets with Boehringer Ingelheim NANTES, France – April 23, 2025, 6:00 p.m. CET - OSE …
OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025
GlobeNewswire
·
April 23, 2025
OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025 Présentations sur l’actif propriétaire Tedopi® et sur deux inhibiteurs de SIRPα développés en partenariat avec Boehringer Ingelheim NANTES, France, 23 avril …
Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Individualized Therapeutic Cancer Vaccine TG4050 at ASCO 2025
GlobeNewswire
·
April 23, 2025
Strasbourg, France, April 23, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will be delivering a rapid oral presentation of randomized Phase I …
ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025
GlobeNewswire
·
April 23, 2025
ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025 Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET– ImCheck Therapeutics announced today an oral presentation at the upcoming …
Riyadh Air Sets High Safety Standards for Pilot Training by Selecting CEFA Aviation’s FAS
EIN Presswire
·
April 23, 2025
COLMAR, FRANCE, April 23, 2025 /EINPresswire.com/ -- Riyadh Air, Saudi Arabia’s premier new flag carrier, has selected CEFA Aviation, a leading provider of flight data animation solutions, to provide its CEFA FAS (Flight Animation System) software to …
Coave Therapeutics Expands into the US with Strategic Appointment of Romain Pettenaro as VP of Business Development
GlobeNewswire
·
April 23, 2025
Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and establish its presence in the Boston biotech hub Paris, France, and Cambridge, MA, USA - April 23, 2025 – Coave Therapeutics (‘Coave’), a …
Philipp Rüede appointed CEO SCOR L&H and Member of SCOR’s Executive Committee
GlobeNewswire
·
April 23, 2025
Press release 23 April 2025 - N° 08 Philipp Rüede appointed CEO SCOR L…